LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS WITH AND WITHOUT PRIOR ANTI-TUMOR NECROSIS FACTOR EXPOSURE: 96-WEEK OUTCOMES FROM THE RAPID-PSA TRIAL
Author(s):
Mease, P.J.; Fleischmann, R.; Wollenhaupt, J.; Deodhar, A.; Gladman, D.; Hoepken, B.; Peterson, L.; Heijde, D. van der
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, p. 90-90
